Boyang Sun
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Comparative safety profiles of antibody-drug conjugates: a real-world analysis of monotherapy and combination regimens in solid tumors.
Journal: Drug delivery
Published: August 06, 2026
Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 05, 2026
Engineered metallo-albumin nanoscaffolds that target lymph nodes, deliver antigens and activate STING for cancer immunotherapy.
Journal: Biomaterials
Published: December 08, 2025
Multiomics Integration Identifies a Molecular Subtype of Intrahepatic Cholangiocarcinoma With Enhanced Benefit From Adjuvant Therapy.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: November 17, 2025
Study of the blood-brain barrier-penetrating KRAS G12C inhibitor JMKX1899 in KRAS G12C-mutated NSCLC with brain metastases.
Journal: Journal of the National Cancer Center
Published: July 07, 2025
Structure-based classification for differential tyrosine kinase inhibitors efficacy of EGFR exon 19 deletions in non-small cell lung cancer.
Journal: Science China. Life sciences
Published: May 30, 2025
Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 21, 2025
Phenotypic age acceleration and early-onset lung cancer: a case-control and prognostic cohort study involving multiple clinical centres with validation in the UK Biobank.
Journal: EBioMedicine
Published: April 16, 2025
Tumor-Informed ctDNA in Guiding First-Line Immunochemotherapy in Advanced Non-Small Cell Lung Cancers.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 15, 2025
Chinese Society of Clinical Oncology Non-small Cell Lung Cancer (CSCO NSCLC) guidelines in 2024: key update on the management of early and locally advanced NSCLC.
Journal: Cancer biology & medicine
Published: February 25, 2025
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial.
Journal: The Lancet. Respiratory medicine
Published: February 19, 2025
Nitrene-mediated aminative N-N-N coupling: facile access to triazene 1-oxides.
Journal: Chemical science
Published: January 07, 2025
Last Updated: 09/26/2026